Braveheart Bio, Inc. (NASDAQ:BRVE) IPO

Braveheart Bio, Inc.

IPO

Priced at US$18.00 a share on Aug 5, 2026.

Price
US$18.00 a share
Shares offered
21,250,000 shares of common stock
Offering size
US$382.5 million
Underwriters' option
Up to 3,187,500 more shares
Listing
BRVE on the Nasdaq Global Market
Underwriters
Goldman Sachs & Co. LLC, Jefferies, TD Cowen, Stifel, Cantor · In the order on the cover
Shares delivered
On or about Aug 7, 2026

Steps

StepWhen
Draft sent to the SEC in confidenceApr 29, 2026
Filed publiclyJul 15, 2026
Amended onceJul 30, 2026
Shares registered with an exchangeAug 3, 2026
Declared effective by the SECAug 5, 2026
Final prospectus, with the priceAug 6, 2026

From the cover of the final prospectus (424B4) filed Aug 6, 2026